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The facial contour is affected more strongly by the vol-
ume of subcutaneous fat tissue than by the underlying 
anatomic structures, bone, and musculature. The symmet-
rical and adequate distribution of subcutaneous fat tissue 
is considered essential to an aesthetically pleasing face.1 
Lipoatrophy of the face is an uncommon disease that 
involves a reduction in facial adipose tissue, causing ab-
normal indentation and asymmetry of the face.2,3 People 
with facial lipoatrophy may experience low self-esteem, 
depression, and social isolation.2
Facial lipoatrophy can occur due to natural or pathologi-
cal processes.3 Natural or physiological lipoatrophy refers 
to the loss of facial fat due to senescence.2 This type of 
adipose tissue loss generally starts at the age of 20 to 30 
years and progresses gradually. Natural lipoatrophy is usu-
ally bilateral. In contrast, when pathological adipose tissue 
loss occurs, patients may lose their facial symmetry to a 
serious degree within a short time. Common sites of adi-
pose tissue loss are the cheeks, temples, and pre-auricular 
region.
Currently, the molecular pathways contributing to the 
manifestation of this disease remain unclear. Several con-
tributing factors are known, and the most commonly es-
tablished cause is infection with HIV. The treatment for 
this disease (antiretroviral therapy), as well as HIV infec-
tion itself, can trigger inflammation of the subcutaneous 
adipose tissue, causing the subcutaneous fat to shrink in 
volume.3 Lupus erythematosus is another systemic dis-
ease that causes the inflammatory loss of subcutaneous 
adipose tissue, known as panniculitis. Localized sclero-
derma also involves panniculitis, although it initially is 
characterized by an inflammatory erythematous patch.3
Until recently, due to the ambiguity and rarity of facial 
lipoatrophy, neither standard clinical criteria for diagnosis 
nor proper treatment options had been established for this 
condition.4,5 However, studies of facial atrophy have been 
regularly reported in the literature, and the symmetry of 
the facial contour has become more important for many 
people in terms of managing their social life and mental 
health in modern society.2-5 The present case report aimed 
to provide information about this rare disease of unclear 
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origin to oral and maxillofacial specialists and to help 
characterize this disease entity more clearly.
Case Report
Case 1
A 34-year-old man presented to our hospital with con-
cerns about a left facial depression that he had first noticed 
a year prior. He was also suffering from muscle spasm 
and pain in the left face, especially during meals. He re-
ported experiencing frequent headaches, which he thought 
were caused by the muscle spasms. He had no systemic 
diseases, and no noteworthy results were obtained from a 
complete blood count, a blood glucose test, and a test of 
his serum cholesterol levels. Additionally, the patient was 
HIV-negative. He underwent computed tomography (CT) 
and magnetic resonance (MR) imaging as well as an elec-
tromyogram. On the CT and MR images, his left buccal 
fat pad showed a drastically decreased volume relative to 
the right side (Figs. 1A-C). The MR images showed no 
pathologic signal in the nearby soft tissues (Fig. 1B). On 
the CT images, the left parotid gland showed a decrease 
in size, with local enhancement in the hilar portion. The 
left Stensen duct was dilated and showed enhancement 
as well (Fig. 1D). The patient underwent a nerve block 
of the masseteric branch of the mandibular nerve, which 
partially relieved the involuntary masseter muscle spasm. 
He underwent nerve block therapy twice more separated 
by a 1-month interval, and the muscle spasm disappeared 
completely, although he was still worried about the facial 
deformity. However, 3 months later, muscle spasm reap-
peared in the left temporal region. Nerve block was per-
Fig. 1. A. A clinical photo of the patient in case 1. Facial asymmetry due to depression of the left buccal cheek is noted. B. A T1-weight-
ed magnetic resonance (MR) image of the patient shows a prominent loss of left buccal fat tissue, while the left masseter muscle shows a 
normal signal and volume compared to the right side. C. A contrast-enhanced computed tomography (CT) image also reveals a prominent 
depression on the left buccal cheek (hollow arrow) compared to the right side. D. The left parotid gland shows a decrease in size and local 
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formed on the left masseteric and deep temporal branches 
of the mandibular nerve. The patient’s symptoms were 
alleviated by the time of the 2-month follow-up visit, and 
after several additional nerve block treatments, he is now 
receiving regular follow-up.
Case 2
A 65-year-old man presented to our hospital with re-
current pain in the left mandible. The pain had started 4 
months before, and tooth extraction with saucerization 
had been performed at another hospital. The patient had 
regularly undergone kidney dialysis for 15 years due to 
end-stage renal disease (ESRD) and also suffered from ad-
renal deficiency. Panoramic radiography was performed. 
It showed diffuse sclerotic changes around the tooth ex-
traction sockets and several osteolytic radiolucencies un-
der the mandibular canal (Fig. 2A). Under suspicion of 
osteomyelitis, the patient underwent contrast-enhanced 
CT imaging (LightSpeed VCT; General Electric Medical 
Systems, Milwaukee, WI, USA). The CT images also re-
vealed features of osteomyelitis on the left mandible (Fig. 
2B). After curettage and medication, the patient’s symp-
toms were relieved. However, 8 months later, he again felt 
pain in the left mandible, which led to a high suspicion 
of recurrent osteomyelitis. Contrast-enhanced CT images 
were obtained again and revealed the progression of oste-
olysis of the mandible. In addition to the osteomyelitis-re-
lated findings, the subcutaneous fat tissue of the occipital, 
periauricular, temporal, and periorbital regions, as well as 
the neck, exhibited prominently reduced volume (Figs. 2C 
and D). Additionally, the remaining subcutaneous and in-
termuscular fat layer of the head and neck and both sides 
Fig. 2. Panoramic radiography (A) and computed tomography (CT) images (B) in the bone window show diffuse sclerosis around tooth 
extraction sockets and trabecular bone reduction adjacent to the mandibular canal. C. A contrast-enhanced CT image reveals bone marrow 
enhancement in the left mandible, while the subcutaneous fat tissue shows no signs of pathology. D. A contrast-enhanced CT image taken 8 
months later shows that the subcutaneous fat layer of the head and neck had been obliterated. Both parotid glands show increased enhance-
ment (arrow: periorbital and temporal region, arrow head: preauricular and upper buccal region, open arrow: lower buccal and occipital 
region, asterisk: parotid gland).
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of the parotid gland showed increasing attenuation.
 
Case 3
A 61-year-old man presented to our hospital with a 
chief concern of fat tissue loss in his right buccal cheek 
area. He had experienced the loss of volume of his left 
cheek 7 to 8 years prior, and his right cheek had started to 
lose fat rapidly 2 months before, even as his overall body 
weight had remained constant. Except for the severe de-
pression on his cheek, he reported no symptoms. Blood 
testing revealed that he had mild anemia. He had arthritis 
of the wrist, diagnosed as rheumatoid arthritis. Ultraso-
nography of the abdomen and endoscopy of the stomach 
and intestines revealed non-specific findings in the pan-
creas, liver, spleen, and intestine. MR imaging (Signa 
HDe; General Electric Medical Systems) at 1.5 T showed 
a complete loss of the subcutaneous fat tissue of the facial 
region. The masseter muscle, facial muscles, and neck 
muscles were very close to the cutaneous layer (Fig. 3). 
The parotid glands exhibited no pathologic changes but 
were nearly contacting the cutaneous layer on both sides. 
The bony structures were also intact, with a normal bone 
marrow signal and no evidence of severe trauma or infec-
tion. Based on the clinical and imaging findings, a diag-
nosis of facial lipoatrophy was made.
Discussion
Facial lipoatrophy is not life-threatening; however, pa-
tients’ psychosocial health can be considerably affected by 
this condition. Two of the patients described in the present 
report visited our hospital with reports of facial depres-
sion, and the other patient had incidentally detected facial 
atrophy. The known causes of lipoatrophy are immune 
system-related diseases, including HIV infection, lupus er-
ythematosus, and localized scleroderma.3 Those diseases 
were not present in the patients discussed in this report. In 
contrast, the patient in case 2 had adrenal deficiency and 
ESRD, while the patient in case 3 had mild anemia and was 
rheumatoid factor-positive. Scant previous research has 
been presented regarding an association between those dis-
eases and lipoatrophy.4,5 A case report with a literature re-
view published in 2004 stated that, of 220 cases, only 1 pa-
tient had facial lipoatrophy associated with rheumatoid ar-
thritis.4,5 This report also suggested an association between 
lipoatrophy and renal disorders, especially membranop-
roliferative glomerulonephritis (MPGN), as the 220 cases 
included 45 cases of lipoatrophy (approximately 22%) with 
histopathologically proven MPGN. MPGN is a type of 
glomerulonephritis that may progress into renal dysfunc-
tion, including ESRD.6 However, the studies covered in 
that review were focused on the onset of renal disease due 
to lipoatrophy, the precise mechanism of which is not yet 
clear. The patient in case 2 had suffered from renal disease 
for 15 years, whereas the lipoatrophic changes had taken 
place more recently. It is thus difficult to conclude that the 
renal disease developed as a consequence of lipoatrophy; 
however, the patient’s renal condition did require close ex-
Fig. 3. T2-weighted (A) and T1-weighted (B) magnetic resonance images demonstrate severe bilateral loss of the buccal subcutaneous adi-
pose tissue in the patient in case 3. The underlying facial and masticatory muscles and parotid glands show no abnormal signal intensity.
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amination, since it could have become severe (with a poor 
prognosis) due to the sudden onset of lipoatrophic changes.
Osteomyelitis was noted on the left mandible of the 
patient in case 2 after tooth extraction. Misra et al. noted 
that infection may be a preceding factor of lipoatrophy.5 
The most commonly reported infectious disease preced-
ing lipoatrophy is measles, although 1 report has described 
lipoatrophy of the face within a few weeks after tooth ex-
traction.5,7 In case 2, on the follow-up CT images, the sub-
cutaneous and intermuscular fat layers of the head and neck 
region showed a diffuse increase in attenuation, which is a 
sign of inflammation. Such general inflammatory changes 
of the subcutaneous layer were not observed in the other 
2 patients, in whom only a severe loss of fat volume was 
demonstrated. Considering that the patient in case 2 had 
systemic diseases that were closely related to the immune 
system, the infection may have spread extensively, making 
it a possible preceding factor for lipoatrophy. 
Unlike the patients in case 2 and 3, the patient in case 
1 was relatively young and healthy and had no apparent 
systemic disease. According to the 2003 study conducted 
by Misra et al., facial lipoatrophy without any evidence 
regarding etiology was the most common type reported in 
the literature.8 The patient in case 1 was also different from 
the other patients in that he had discomfort in the affected 
facial region. Specifically, he complained of muscle spasm 
and tenderness on the left side of the face during chewing. 
Lipoatrophy in the extremities presenting with muscle pain 
has been reported, but those cases were confirmed to be 
myositis on MR images.9 However, the electromyogram 
and MR images of the patient in case 1 showed no specific 
pathologic findings associated with his facial and masti-
catory muscles. Although his left cheek had completely 
lost its subcutaneous fat tissue and his skin was slightly 
thinned, the ipsilateral masseter muscle maintained its orig-
inal volume and showed a normal signal compared to that 
on the right side. The parotid gland on the affected side 
showed inflammatory and atrophic changes as its volume 
decreased, and the hilar region was contrast-enhanced on 
the CT images. Moreover, also on the CT images, the left 
Stensen duct was thickened and contrast-enhanced, which 
is a sign of sialodochitis.10 According to previous research, 
significant and rapid fat loss may cause increased tightness, 
with the skin positioned directly on the facial bone.3 An in-
dividual may feel discomfort due to this abnormal tension 
of the skin.3 This inflammatory changes of the duct and 
gland may be due to stenosis of the main duct caused by 
facial skin tension. The presence of tenderness when chew-
ing may also be explained by these inflammatory changes 
in the duct and gland. Still, whether this explanation is rel-
evant to this case is uncertain, because the patient felt that 
the frequency of involuntary muscle spasms in the masseter 
muscle decreased after an injection of anesthetic into the 
masseteric branch of the mandibular nerve. This suggests 
that his symptoms may have been neurogenic. Progres-
sive facial hemiatrophy, which is known as Parry-Rom-
berg syndrome, is a neurocutaneous syndrome involving 
the progressive loss of the subcutaneous adipose tissue in 
the facial region innervated by the fifth cranial nerve.11,12 
The disease varies from mild to severe. In the mild type, 
the facial depression is barely perceptible, while in the se-
vere type, facial disfigurement is prominent and involves 
the underlying bone and muscle.12 The pathogenesis of 
this disease is not well known. Genetic alterations during 
embryogenesis, viral or bacterial infections, and traumatic 
nerve injury have been proposed as etiologies. In a previ-
ous study, 45% of patients exhibited migraine and/or facial 
pain due to trigeminal neuralgia.12 Some patients have been 
reported to exhibit lipoatrophic changes involving the sali-
vary gland, as in one of the present cases.13 Parry-Romberg 
syndrome is very rare (1 case per 700,000 individuals) and 
usually occurs in the first or second decade of life, whereas 
our patient was older.12 However, the clinical manifesta-
tions of our patient were similar to those of this disease, 
meaning that this syndrome cannot be completely ruled out 
and further clinical observation is required.
In conclusion, lipoatrophy of the face is an uncommon 
disease that seems to be associated with various inherited 
or acquired systemic diseases. A system for the diagnosis 
and grading of this disease has been established recently, 
although a framework for treatment is still absent. Thus, 
oral and maxillofacial specialists should be aware of this 
entity and perform careful examinations to determine if 
it is related to an unknown systemic or infectious disease 
in affected patients. Patients should be carefully followed 
up with because lipoatrophy may interrupt renal function. 
Additionally, it is important to correct the disfigurement, 
since asymmetric facial contour can lead to social stigma 
and negative psychological effects on patients.
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